Impacts of Matrix Metalloproteinase-11 Genotypes on Pterygium Risk.

IF 1.6 4区 医学 Q4 ONCOLOGY
Ning-Yi Hsia, Hung-Chih Chen, Hung-Wen Tsai, Te-Chun Hsia, Pei-Shin Hu, Yun-Chi Wang, Hou-Yu Shih, Wen-Shin Chang, DA-Chuan Cheng, DA-Tian Bau, Chia-Wen Tsai
{"title":"Impacts of Matrix Metalloproteinase-11 Genotypes on Pterygium Risk.","authors":"Ning-Yi Hsia, Hung-Chih Chen, Hung-Wen Tsai, Te-Chun Hsia, Pei-Shin Hu, Yun-Chi Wang, Hou-Yu Shih, Wen-Shin Chang, DA-Chuan Cheng, DA-Tian Bau, Chia-Wen Tsai","doi":"10.21873/anticanres.17308","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>The dysregulation of matrix metalloproteinase (MMP) proteins has been reported to be involved in the etiology of pterygium. However, studies about the role of matrix metalloproteinase-11 (MMP-11) are lacking. This study is the first to examine the genomic role of MMP-11 in pterygium.</p><p><strong>Materials and methods: </strong>The genotypes of MMP-11 rs738791, rs2267029, rs738792, and rs28382575 were determined in 140 pterygium cases and 280 non-pterygium controls by utilizing polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and direct sequencing.</p><p><strong>Results: </strong>The genotypic frequencies of MMP-11 rs738792 TT, CT and CC were 40.0%, 50.7%, and 9.3% in the pterygium group, significantly different from those in the non-pterygium group (55.0%, 37.1%, and 7.9%, respectively; p for trend=0.0139). Specifically, individuals carrying the variants CT and CC had a 1.88- and 1.63-fold odds ratio of pterygium risk [95% confidence interval (CI)=1.22-2.89 and 0.77-3.44, p=0.0054 and 0.2834, respectively]. In the dominant model, individuals carrying CT+CC had significantly higher pterygium risk (odds ratio=1.83, 95%CI=1.21-2.77, p=0.0052). No association was found for other MMP-11 polymorphisms. Allelic analysis showed that MMP-11 rs738792 C allele was significantly associated with pterygium risk (odds ratio=1.48, 95%CI=1.08-2.01, p=0.0169). for the variant alleles of other MMP-11 polymorphisms were not associated with pterygium risk.</p><p><strong>Conclusion: </strong>The MMP-11 rs738792 genotypes can serve as a predictive marker for pterygium risk in Taiwanese. Additionally, elucidating the role of MMP-11 in the pathogenesis of pterygium could inform targeted therapies based on MMP-11 modulation.</p>","PeriodicalId":8072,"journal":{"name":"Anticancer research","volume":"44 11","pages":"4825-4831"},"PeriodicalIF":1.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anticancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/anticanres.17308","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background/aim: The dysregulation of matrix metalloproteinase (MMP) proteins has been reported to be involved in the etiology of pterygium. However, studies about the role of matrix metalloproteinase-11 (MMP-11) are lacking. This study is the first to examine the genomic role of MMP-11 in pterygium.

Materials and methods: The genotypes of MMP-11 rs738791, rs2267029, rs738792, and rs28382575 were determined in 140 pterygium cases and 280 non-pterygium controls by utilizing polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and direct sequencing.

Results: The genotypic frequencies of MMP-11 rs738792 TT, CT and CC were 40.0%, 50.7%, and 9.3% in the pterygium group, significantly different from those in the non-pterygium group (55.0%, 37.1%, and 7.9%, respectively; p for trend=0.0139). Specifically, individuals carrying the variants CT and CC had a 1.88- and 1.63-fold odds ratio of pterygium risk [95% confidence interval (CI)=1.22-2.89 and 0.77-3.44, p=0.0054 and 0.2834, respectively]. In the dominant model, individuals carrying CT+CC had significantly higher pterygium risk (odds ratio=1.83, 95%CI=1.21-2.77, p=0.0052). No association was found for other MMP-11 polymorphisms. Allelic analysis showed that MMP-11 rs738792 C allele was significantly associated with pterygium risk (odds ratio=1.48, 95%CI=1.08-2.01, p=0.0169). for the variant alleles of other MMP-11 polymorphisms were not associated with pterygium risk.

Conclusion: The MMP-11 rs738792 genotypes can serve as a predictive marker for pterygium risk in Taiwanese. Additionally, elucidating the role of MMP-11 in the pathogenesis of pterygium could inform targeted therapies based on MMP-11 modulation.

基质金属蛋白酶-11 基因型对翼状胬肉风险的影响。
背景/目的:据报道,基质金属蛋白酶(MMP)蛋白的失调与翼状胬肉的病因有关。然而,有关基质金属蛋白酶-11(MMP-11)作用的研究还很缺乏。本研究首次探讨了 MMP-11 在翼状胬肉中的基因组作用:采用聚合酶链式反应-限制性片段长度多态性(PCR-RFLP)和直接测序法测定了140例翼状胬肉病例和280例非翼状胬肉对照的MMP-11 rs738791、rs2267029、rs738792和rs28382575的基因型:翼状胬肉组中MMP-11 rs738792 TT、CT和CC的基因型频率分别为40.0%、50.7%和9.3%,与非翼状胬肉组(分别为55.0%、37.1%和7.9%;趋势p=0.0139)有显著差异。具体来说,携带 CT 和 CC 变异的个体患翼状胬肉的几率比分别为 1.88 倍和 1.63 倍[95% 置信区间(CI)=1.22-2.89 和 0.77-3.44,p=0.0054 和 0.2834]。在显性模型中,携带 CT+CC 的个体翼状胬肉风险明显更高(几率比=1.83,95%CI=1.21-2.77,p=0.0052)。其他 MMP-11 多态性没有发现相关性。等位基因分析表明,MMP-11 rs738792 C等位基因与翼状胬肉风险显著相关(几率比=1.48,95%CI=1.08-2.01,p=0.0169),而其他MMP-11多态性的变异等位基因与翼状胬肉风险无关:结论:MMP-11 rs738792基因型可作为台湾人翼状胬肉风险的预测标记。结论:MMP-11 rs738792基因型可作为台湾人翼状胬肉风险的预测标志物,此外,阐明MMP-11在翼状胬肉发病机制中的作用可为基于MMP-11调节的靶向治疗提供依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Anticancer research
Anticancer research 医学-肿瘤学
CiteScore
3.70
自引率
10.00%
发文量
566
审稿时长
2 months
期刊介绍: ANTICANCER RESEARCH is an independent international peer-reviewed journal devoted to the rapid publication of high quality original articles and reviews on all aspects of experimental and clinical oncology. Prompt evaluation of all submitted articles in confidence and rapid publication within 1-2 months of acceptance are guaranteed. ANTICANCER RESEARCH was established in 1981 and is published monthly (bimonthly until the end of 2008). Each annual volume contains twelve issues and index. Each issue may be divided into three parts (A: Reviews, B: Experimental studies, and C: Clinical and Epidemiological studies). Special issues, presenting the proceedings of meetings or groups of papers on topics of significant progress, will also be included in each volume. There is no limitation to the number of pages per issue.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信